Avoiding common mistakes in meta-analysis: Understanding the distinct roles of Q, I-squared, tau-squared, and the prediction interval in reporting heterogeneity

被引:42
作者
Borenstein, Michael [1 ,2 ]
机构
[1] Biostat Inc, Englewood, NJ USA
[2] 473 West End Ave, New York, NY 10024 USA
关键词
confidence interval; heterogeneity; I-2; I-squared; meta-analysis; prediction interval; systematic review; tau-squared; DISORDER; I-2;
D O I
10.1002/jrsm.1678
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In any meta-analysis, it is critically important to report the dispersion in effects as well as the mean effect. If an intervention has a moderate clinical impact on average we also need to know if the impact is moderate for all relevant populations, or if it varies from trivial in some to major in others. Or indeed, if the intervention is beneficial in some cases but harmful in others. Researchers typically report a series of statistics such as the Q-value, the p-value, and I2, which are intended to address this issue. Often, they use these statistics to classify the heterogeneity as being low, moderate, or high and then use these classifications when considering the potential utility of the intervention. While this practice is ubiquitous, it is nevertheless incorrect. The statistics mentioned above do not actually tell us how much the effect size varies. Classifications of heterogeneity based on these statistics are uninformative at best, and often misleading. My goal in this paper is to explain what these statistics do tell us, and that none of them tells us how much the effect size varies. Then I will introduce the prediction interval, the statistic that does tell us how much the effect size varies, and that addresses the question we have in mind when we ask about heterogeneity. This paper is adapted from a chapter in "Common Mistakes in Meta-Analysis and How to Avoid Them." A free PDF of the book is available at .
引用
收藏
页码:354 / 368
页数:15
相关论文
共 21 条
  • [1] Efficacy of tocilizumab in COVID-19: A systematic review and meta-analysis
    Aziz, Muhammad
    Haghbin, Hossein
    Abu Sitta, Emad
    Nawras, Yusuf
    Fatima, Rawish
    Sharma, Sachit
    Lee-Smith, Wade
    Duggan, Joan
    Kammeyer, Joel A.
    Hanrahan, Jennifer
    Assaly, Ragheb
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (03) : 1620 - 1630
  • [2] Borenstein M., 2019, COMMON MISTAKES META
  • [3] Borenstein M., ANESTH ANALG
  • [4] Borenstein M., 2022, Comprehensive meta-analysis version 4
  • [5] Borenstein M, 2021, Introduction to meta-analysis, DOI [10.1002/9780470743386, DOI 10.1002/9780470743386]
  • [6] Borenstein Michael, 2022, J Clin Epidemiol, V152, P281, DOI 10.1016/j.jclinepi.2022.10.003
  • [7] Research Note: In a meta-analysis, the I2 index does not tell us how much the effect size varies across studies
    Borenstein, Michael
    [J]. JOURNAL OF PHYSIOTHERAPY, 2020, 66 (02) : 135 - 139
  • [8] Basics of meta-analysis: I2 is not an absolute measure of heterogeneity
    Borenstein, Michael
    Higgins, Julian P. T.
    Hedges, Larry V.
    Rothstein, Hannah R.
    [J]. RESEARCH SYNTHESIS METHODS, 2017, 8 (01) : 5 - 18
  • [9] Posttraumatic Stress Disorder in Parents of Children With Chronic Illnesses: A Meta-Analysis
    Cabizuca, Mariana
    Marques-Portella, Carla
    Mendlowicz, Mauro V.
    Coutinho, Evandro S. F.
    Figueira, Ivan
    [J]. HEALTH PSYCHOLOGY, 2009, 28 (03) : 379 - 388
  • [10] Efficacy of Methylphenidate for Adults with Attention-Deficit Hyperactivity Disorder A Meta-Regression Analysis
    Castells, Xavier
    Antoni Ramos-Quiroga, Josep
    Rigau, David
    Bosch, Rosa
    Nogueira, Mariana
    Vidal, Xavier
    Casas, Miguel
    [J]. CNS DRUGS, 2011, 25 (02) : 157 - 169